PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsAnakinra
Kineret(anakinra)
Kineret (anakinra) is a protein pharmaceutical. Anakinra was first approved as Kineret on 2001-11-14. It is used to treat cryopyrin-associated periodic syndromes and rheumatoid arthritis in the USA. It has been approved in Europe to treat rheumatoid arthritis.
Download report
Favorite
COVID-19
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
musculoskeletal diseasesD009140
hereditary congenital and neonatal diseases and abnormalitiesD009358
skin and connective tissue diseasesD017437
immune system diseasesD007154
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Kineret
Drug Products
FDA
EMA
Reference product - 351(a)
Reference product - 351(a)
Interchangeable product - 351(k)
Interchangeable product - 351(k)
Biosimilar product - 351(k)
Biosimilar product - 351(k)
Anakinra
Tradename
Proper name
Company
Number
Date
Products
KineretanakinraOrphan MedicalN-103950 RX2001-11-14
1 products
Labels
FDA
EMA
Brand Name
Status
Last Update
kineretBiologic Licensing Application2026-04-03
Agency Specific
FDA
EMA
Expiration
Code
anakinra, Kineret, Swedish Orphan Biovitrum AB (publ)
2027-12-18Orphan excl.
Patent Expiration
No data
ATC Codes
L: Antineoplastic and immunomodulating agents
— L04: Immunosuppressants
— L04A: Immunosuppressants
— L04AC: Interleukin inhibitors
— L04AC03: Anakinra
HCPCS
No data
Clinical
Clinical Trials
219 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Juvenile arthritisD001171EFO_1002007M08——2114
Adult-onset still's diseaseD016706EFO_0007135M06.1——21—3
Familial mediterranean feverD010505—M04.1———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Mucocutaneous lymph node syndromeD009080EFO_0004246M30.3—11——2
Covid-19D000086382—U07.1—11——2
InfectionsD007239EFO_0000544——11——1
Sars-cov-2D000086402———11——1
Respiratory signs and symptomsD012818————1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ArthritisD001168EFO_0005856M05-M14—1——12
Non-hodgkin lymphomaD008228—C85.9—1———1
B-cell lymphomaD016393———1———1
Gouty arthritisD015210———1———1
Meniere diseaseD008575EFO_0006862H81.0—1———1
Cytokine release syndromeD000080424—D89.83—1———1
MucopolysaccharidosesD009083—E76.311———1
Mucopolysaccharidosis iiiD009084—E76.2211———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LeukemiaD007938—C951————1
B-cell chronic lymphocytic leukemiaD015451—C91.11————1
Lymphoid leukemiaD007945—C911————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Rheumatoid arthritisD001172EFO_0000685M06.9————11
Cryopyrin-associated periodic syndromesD056587—M04.2————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameAnakinra
INNanakinra
Description
Interleukin-1 receptor antagonist protein precursor (IL-1ra) (IRAP)
Classification
Protein
Drug classinterleukin receptor antagonists: interleukin-1 (IL-1) receptor antagonists
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL IDCHEMBL1201570
ChEBI ID—
PubChem CID—
DrugBankDB00026
UNII ID9013DUQ28K (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Anakinra
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 9,999 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
14,776 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use